Case Study

Owlstone

Owlstone

Pages 2 Pages

A?G  ?l?E?? Owlstone Company Owlstone Competition: Autumn 2013 (Cancer) Innovation: LuCID (Lung Cancer Indicator Detection)  dŽlAuA?A?E? £1,094,772 awarded for Phase 1 & 2 development stages ^A|sYO?lŽlSGE,^? £82m Estimated saving per annum Product availability: 2017 SUMMARY The LuCID (Lung Cancer Indicator Detection) project will allow Owlstone’s existing chemical detection technology to be used to diagnose lung cancer, by

Join for free to read